China Cardiac Monitoring Device Market Size by Product, End Use - Revenue Pool Analysis, Margin Structure Assessment, Capital Flow Trends, Competitive Benchmarking & Forecast to 2030
Overview
The China Cardiac Monitoring Device Market size was valued at USD 2.93 Billion in 2023 and the total China Cardiac Monitoring Device Market revenue is expected to grow at a CAGR of 5.30 % from 2023 to 2030, reaching nearly USD 4.21 Billion.
China Cardiac Monitoring Device Market Overview
The China Cardiac Monitoring Device Market is comprehensively analyzed in this MMR research report, along with a moderate and long-term growth outlook. It offers a comprehensive summary of the market dynamics, trends, and insights, growth factors and constraints, competitive landscape, segmentation, healthcare laws and regulations, and outlook for the future. The rising demand for cardiac monitoring devices across various segments is driving strong unit sales, with estimations exceeding 165 million units by 2030. The Technological Advancement and premium features impact the Average Selling Price (ASP), which contributes to the overall revenue growth. Pacemakers, defibrillators, and cardiac resynchronization treatment devices are included in this market sector, which is expected to generate a significant amount of revenue by 2030. The demand for affordable and accessible portable monitoring solutions is fuelling robust growth in this segment, projected to reach USD xx.xx billion by 2030.
To know about the Research Methodology :- Request Free Sample Report
The Rise of Integrated Cardiac Monitoring and Telemedicine
The trend of increased integration between cardiac monitoring devices and telemedicine solutions is rapidly transforming healthcare, particularly in China. The integration facilitates real-time transmission of cardiac data to healthcare providers, enabling early detection of abnormalities. This proactive approach to healthcare leads to timely interventions, reducing the severity of conditions and potentially lowering healthcare costs. The impact on the China Cardiac Monitoring Device market includes increased demand for integrated solutions, technological advancements, improved patient outcomes, and a shift towards more cost-effective and patient-centric healthcare delivery.
Numbers Showing Impact on the Market
By 2023, The Chinese Government Has Invested over USD 4.7 Billion in Telemedicine Development. China boasts the world's largest telemedicine network, connecting over 80,000 medical institutions across all levels. The Remote consultations in China reached 294 million in 2023, demonstrating widespread adoption. The "National Digital Health Project for Major Chronic Diseases" prioritizes remote monitoring for cardiovascular conditions, aiming to cover 550 million patients by 2030.
The “Healthy China 2030” Initiative Launched by the Chinese Government and its Impact on Cardiac Monitoring Device Market.
1. The "Healthy China 2030" initiative launched in 2016 is a national commitment to improve the health and well-being of all Chinese citizens. With a strong emphasis on digital health and chronic disease management, it presents significant opportunities for the cardiac monitoring device market.
2. Cardiovascular diseases are a leading cause of death in China. "Healthy China 2030" prioritizes chronic disease management, aiming to achieve an 83% early diagnosis rate and a 50% mortality reduction for major chronic diseases by 2030. It is estimated to create a massive demand for effective monitoring and diagnostic tools, such as advanced ECG devices and remote patient monitoring platforms.
Healthcare Professional Training
Adequate training of healthcare professionals on using and interpreting data from cardiac monitoring devices is crucial. Well-trained healthcare professionals are expected to efficiently manage patients using cardiac monitoring devices. They leverage the data obtained to make informed decisions, tailor treatment plans, and provide personalized care, thereby contributing to more efficient and effective patient management. According to MMR research, 15-25% of ECGs are misdiagnosed by physicians, potentially leading to missed diagnoses or inappropriate treatment decisions. Proper training on device data interpretation has significantly reduced errors.
China Cardiac Monitoring Device Market Segment Analysis
By product Type, The Chinese cardiac monitoring market is expected to grow, fuelled by an aging population, an increase in chronic disease prevalence, and government initiatives such as "Healthy China 2030." Within this larger landscape, the Cardiac Rhythm Management Devices (CRMD) segment stands out as a key driver of growth, offering promising opportunities for market players. With the largest population over 65 in the globe, China plays a significant role in the CRMD industry. It is estimated to reach over 350 million by 2030, indicating a substantial prospective patient population.
Table: Dominant Players in the China Cardiac Monitoring Device Market, Their focus segment, and Impact on the Market.
| Dominant Players in the Market | Segment Focus | Impact On Market |
| Mindray | Imaging, Monitoring, In-Vitro Diagnostics | Innovation, affordability, remote monitoring solutions |
| Edan Instruments | ECG, Holter Monitors | Cost-effective, reliable devices |
| Lepu Medical | Pacemakers, Stents | Advanced technology, remote monitoring initiatives |
| Huawei | Wearables, AI-powered solutions | Disruption through technology and affordability |
| Shenzhen Mindtech | Dialysis, Blood Purification Equipment | Focus on functional segments |
China Cardiac Monitoring Device Market Scope: Inquire Before Buying
| China Cardiac Monitoring Device Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2023 | Forecast Period: | 2024-2030 |
| Historical Data: | 2018 to 2023 | Market Size in 2023: | US $ 2.93 Bn. |
| Forecast Period 2024 to 2030 CAGR: | 5.30% | Market Size in 2030: | US $ 4.21 Bn. |
| Segments Covered: | by Product | Cardiac Rhythm Management Devices Cardiac Monitoring Devices |
|
| by End Use | Home Healthcare Ambulatory Centers Hospitals Others |
||
Key Players in China Cardiac Monitoring Device Market
1. Mindray Medical International Limited
2. Biolight Meditech Co., Ltd
3. Contec Medical Systems Co., Ltd
4. Creative Medical
5. Edan Instruments, Inc
6. Comen Medical Instruments Co., Ltd
7. United Imaging Healthcare Co., Ltd
8. Nihon Kohden (China) Co., Ltd
9. Siemens Healthineers (China)
10. Philips Healthcare (China)
Frequently Asked Questions:
1. What is the growth rate of Market?
Ans: The China Cardiac Monitoring Device Market is growing at a CAGR of 5.30% during forecasting period 2024-2030.
2. What is scope of the Market report?
Ans: China Cardiac Monitoring Device Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
3. Who are the key players in China Cardiac Monitoring Device Market?
Ans: The important key players in the China Cardiac Monitoring Device Market are – Mindray Medical International Limited, Biolight Meditech Co., Ltd, Contec Medical Systems Co., Ltd, Creative Medical, Edan Instruments, Inc, Comen Medical Instruments Co., Ltd, United Imaging Healthcare Co., Ltd, Nihon Kohden (China) Co., Ltd, Siemens Healthineers (China), Philips Healthcare (China).
4. What is the study period of this Market?
Ans: The Market is studied from 2023 to 2030.